Peregrine to Report First Quarter Fiscal Year 2011 Financial Results After Market on September 9, 2010

2 September 2010, 5:16 am

TUSTIN, CA--(Marketwire - September 2, 2010) - Peregrine Pharmaceuticals, Inc. ( NASDAQ : PPHM ), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today announced that it will report financial results for the first quarter fiscal year 2011 on September 9, 2010 after market and will host a conference call ...... Read More »

More Topics from "News"

• Vita-Tech International Donates Nutritional Products in Africa
• Company Profile for MDLsolutions, Inc.
• Advanced Feeedback Systems Translate to Lower Costs for Fluid Research Meter, Mix, Dispense ...
• NAFA PSW Chapter to Hold Golf Outing in October
• First day of school for Tustin Unified
• Radient Pharmaceuticals Resumes Collaboration to Advance Its Onko-Sure(R) In Vitro Diagnostic Cancer Test in the USA
• Radient Pharmaceuticals Provides Domestic and International Target Market Details for Its Onko-Sure(R) IVD Cancer ...
• Radient Pharmaceuticals Provides Domestic and International Target Market Details for Its Onko-Sure(R) IVD Cancer ...
• 628-Unit Creekside Meadows Apartments Trades